Pyrimidine compounds of general formula in which G is a phenyl optionally substituted with at least one substituent Z or a 5- or 6-membered heteroaromatic optionally substituted with at least one substituent Z; Z independently of one another is (C 1 -C 6) alkyl, (C 1 -C 6) hydroxyalkyl, (C 1 -C 6) alkoxy, (C 1 -C 6) haloalkyl, (C 1 -C 6) haloalkoxy, -S(C 1 -C 6) alkyl, halogen, hydroxyl or cyano, wherein aforementioned alkyls are branched or straight-chain and can be substituted; V is CH 2 or a group S x with x being 0, 1 or 2, whereas one or two hydrogen atoms in the CH 2 group can be replaced by the same or a different substituent K; T is oxygen, CH 2, CHR 1 or CR 1 R 2; R 1 and R 2 independently of one another denote (C 1 -C 8) alkyl, (C 1 -C 8) hydroxyalkyl, (C 1 -C 8) haloalkyl and (C 1 -C 8) hydroxyhaloalkyl, wherein the aforementioned alkyl chains are branched or straight-chain and can be substituted, or R 1 and R 2, together with the carbon atom to which they are bound, form a saturated 3- to 6-membered ring consisting of hydrocarbon groups, optionally substituted with branched or straight-chain (C 1 -C 6) alkyl or hydroxyl groups, which can optionally have one or more heteroatoms; Q is a phenyl, pyrimidyl, pyrazinyl or pyridyl substituted with a substituent X 1 and optionally substituted with at least one substituent X; X 1 is an L-CO 2 R 3 group; X independently of one another is (C 1 -C 6) alkyl, (C 3 -C 6) cycloalkyl, (C 1 -C 6) alkoxy, (C 3 -C 6) cycloalkoxy, (C 1 -C 6) haloalkyl, (C 1 -C 6) haloalkoxy, halogen, hydroxyl, cyano, carboxyl, -NH 2, -NH(C 1 -C 6) alkyl, -N((C 1 -C 6) alkyl) 2, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl, -NH-C -(C 1 -C 6) alkyl, -C -NH 2, -C -NH(C 1 -C 6) alkyl, -C -N((C 1 -C 6) alkyl) 2, -S 2 -NH 2, -S(C 1 -C 6) alkyl, -S -(C 1 -C 6) alkyl, or -S 2 -(C 1 -C 6) alkyl, wherein the aforementioned alkyl chains are branched or straight-chain and can be substituted; R 3 is hydrogen, branched or straight-chain (C 1 -C 6) alkyl; L is a bond, (C 1 -C 6) alkylene, (C 2 -C 6) alkenylene, -O-(C 1 -C 4) alkylene, -NH-(C 1 -C 4) alkylene, or -NR 3 -(C 1 -C 4) alkylene, wherein aforementioned alkylenes or alkenylenes can each be substituted with one or more halogen atoms or wherein aforementioned alkylenes or alkenylenes can be substituted with one or more (C 1 -C 6) alkyl groups, or wherein in aforementioned alkylenes or alkenylenes a CH 2 unit can be replaced by an oxygen atom; n is 1 or 2; K is (C 1 -C 6) alkyl, (C 1 -C 6) alkoxy, (C 1 -C 6) haloalkyl, halogen, hydroxyl or cyano; and m is 0, 1, 2, 3 or 4, with the provisio that the compound is not methyl 2-(4-((2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[a]pyrimidin-4-yl)methyl)phenyl)acetate, as well as pharmacologically tolerable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof. G is a phenyl optionally substituted with at least one substituent Z or a 5- or 6-membered heteroaromatic optionally substituted with at least one substituent Z; Z independently of one another is (C 1 -C 6) alkyl, (C 1 -C 6) hydroxyalkyl, (C 1 -C 6) alkoxy, (C 1 -C 6) haloalkyl, (C 1 -C 6) haloalkoxy, -S(C 1 -C 6) alkyl, halogen, hydroxyl or cyano, wherein aforementioned alkyls are branched or straight-chain and can be substituted; V is CH 2 or a group S x with x being 0, 1 or 2, whereas one or two hydrogen atoms in the CH 2 group can be replaced by the same or a different substituent K; T is oxygen, CH 2, CHR 1 or CR 1 R 2; R 1 and R 2 independently of one another denote (C 1 -C 8) alkyl, (C 1 -C 8) hydroxyalkyl, (C 1 -C 8) haloalkyl and (C 1 -C 8) hydroxyhaloalkyl, wherein the aforementioned alkyl chains are branched or straight-chain and can be substituted, or R 1 and R 2, together with the carbon atom to which they are bound, form a saturated 3- to 6-membered ring consisting of hydrocarbon groups, optionally substituted with branched or straight-chain (C 1 -C 6) alkyl or hydroxyl groups, which can optionally have one or more heteroatoms; Q is a phenyl, pyrimidyl, pyrazinyl or pyridyl substituted with a substituent X 1 and optionally substituted with at least one substituent X; X 1 is an L-CO 2 R 3 group; X independently of one another is (C 1 -C 6) alkyl, (C 3 -C 6) cycloalkyl, (C 1 -C 6) alkoxy, (C 3 -C 6) cycloalkoxy, (C 1 -C 6) haloalkyl, (C 1 -C 6) haloalkoxy, halogen, hydroxyl, cyano, carboxyl, -NH 2, -NH(C 1 -C 6) alkyl, -N((C 1 -C 6) alkyl) 2, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl, -NH-C -(C 1 -C 6) alkyl, -C -NH 2, -C -NH(C 1 -C 6) alkyl, -C -N((C 1 -C 6) alkyl) 2, -S 2 -NH 2, -S(C 1 -C 6) alkyl, -S -(C 1 -C 6) alkyl, or -S 2 -(C 1 -C 6) alkyl, wherein the aforementioned alkyl chains are branched or straight-chain and can be substituted; R 3 is hydrogen, branched or straight-chain (C 1 -C 6) alkyl; L is a bond, (C 1 -C 6) alkylene, (C 2 -C 6) alkenylene, -O-(C 1 -C 4) alkylene, -NH-(C 1 -C 4) alkylene, or -NR 3 -(C 1 -C 4) alkylene, wherein aforementioned alkylenes or alkenylenes can each be substituted with one or more halogen atoms or wherein aforementioned alkylenes or alkenylenes can be substituted with one or more (C 1 -C 6) alkyl groups, or wherein in aforementioned alkylenes or alkenylenes a CH 2 unit can be replaced by an oxygen atom; n is 1 or 2; K is (C 1 -C 6) alkyl, (C 1 -C 6) alkoxy, (C 1 -C 6) haloalkyl, halogen, hydroxyl or cyano; and m is 0, 1, 2, 3 or 4, with the provisio that the compound is not methyl 2-(4-((2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[a]pyrimidin-4-yl)methyl)phenyl)acetate, as well as pharmacologically tolerable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof.